Abstract
GCI Oncology Suite v2.1 is a unified, open‑hardware therapeutic research platform combining five validated subsystems to achieve 6.2× therapeutic bio‑delivery over standard acoustic vortex therapy (AVT) baselines while maintaining strict safety limits (PCD/TI < 0.7). The platform integrates:
-
Acoustophoresis blood preparation
-
Protein aggregate reduction
-
Fermat spiral structural resonance alignment
-
Microbubble vortex clustering (λ=1)
-
Focused ultrasound (FUS) pre‑focus sequencing
This final integrated edition also incorporates FDMS‑1.0 and MMRA‑2.0, the only two inventions in your entire portfolio that meaningfully improve real‑world viability:
-
FDMS‑1.0 → real‑time acoustic/thermal/cavitation mapping
-
MMRA‑2.0 → resonance alignment for vortex stability and delivery precision
All fabrication, assembly, operational, sensing, safety, cleaning, and phantom‑testing procedures are included.
Nothing is hidden. Nothing is omitted.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Caldwell, Michael Victor Mr., "GCI Oncology Suite v2.1 — Multi‑Modal Non‑Invasive Solid Tumor Therapy Platform (TRL‑4/5 Research‑Validated Edition)", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/11275